Full Name
Dr Janet Loesberg
Job Title
Senior Vice President global Medical Affairs
Practice/Company Name
Blueprint Medicines
Speaker Bio
Dr. Janet Loesberg currently serves as Senior Vice President, Global Medical Affairs at Blueprint Medicines, a precision medicine biotech company (NASDAQ: BPMC). She is well recognized for her people leadership, worldwide development, portfolio management and commercial launch experience in the Pharmaceutical industry. She is also a certified executive leadership coach and board advisor. Dr. Loesberg is well regarded for her deep passion and work on diversity & inclusion.
At Janssen:
Janssen, the $36B Pharma sector of JNJ, is creating a future where disease is a thing of the past. As VP, Head of Portfolio & Project Management from 2019 -2021, Dr. Loesberg was responsible for leading optimal resourcing to balance the investment in R&D with potential revenue across the full portfolio of the $8B R&D investment. She led a global organization focused on delivering the extensive pipeline on time and on budget and contributed to the covid vaccine speed to market.
At Bristol Myers Squibb:
BMS, a publicly traded $20B+ Biopharma company, develops and manufactures innovative medicines for the treatment of Cancer, Cardiovascular and Immune diseases. Dr. Loesberg, from 2007-2019, held positions with increasing levels and scope of responsibility. In her last role, she served as the Intercon Regional Vice President for Medical where she led a large organization covering more than 33 countries including China, Brazil, Latin America, Central Europe, Middle East, and India with the focus of launching Opdivo, an Immunotherapy medicine to treat cancer. She was responsible for growing revenue in the region by 28% in 2018, and successfully enabling the launch of Opdivo in China. Prior to this role Dr. Loesberg established another organization responsible for global publications, medical information, content creation, clinical trial operations, and scientific exchange. In this role she had many successes including the enablement of 18+ NEJM publications, a successful acquisition of Amylin and the subsequent divestiture of the diabetes portfolio to AstraZeneca.
At Pfizer Inc.:
Dr. Loesberg held increasing levels of responsibility and established two large US field-based organizations to support the clinical development of all assets and the evidence-based health economic data provided to customers for market access and policy decisions. She was instrumental in launching several drugs to market, including Norvasc and Lipitor.
Board Service:
In addition to her fulltime roles, Janet served as a Trustee for the BMS Patient Assistance Foundation for
10 years. She also served as a board member of the Fresh Air Society, Tamarack Camps in Michigan and as a board member of her local house of worship. Janet currently is an Alumni Recruitment Ambassador for the University of Michigan and serves on the Executive Leadership Board for All in Together (aitogether.org).
Awards and Recognitions:
She was recognized by the Healthcare Businesswomen’s Association with the Rising Star and Luminary Awards. Dr. Loesberg is well recognized for founding and leading company organizations for empowering women to have equal career opportunities.
Personal:
Janet holds a Pharm. D degree from the University of Michigan. She enjoys reading, traveling, and spending time with her husband and daughters.
At Janssen:
Janssen, the $36B Pharma sector of JNJ, is creating a future where disease is a thing of the past. As VP, Head of Portfolio & Project Management from 2019 -2021, Dr. Loesberg was responsible for leading optimal resourcing to balance the investment in R&D with potential revenue across the full portfolio of the $8B R&D investment. She led a global organization focused on delivering the extensive pipeline on time and on budget and contributed to the covid vaccine speed to market.
At Bristol Myers Squibb:
BMS, a publicly traded $20B+ Biopharma company, develops and manufactures innovative medicines for the treatment of Cancer, Cardiovascular and Immune diseases. Dr. Loesberg, from 2007-2019, held positions with increasing levels and scope of responsibility. In her last role, she served as the Intercon Regional Vice President for Medical where she led a large organization covering more than 33 countries including China, Brazil, Latin America, Central Europe, Middle East, and India with the focus of launching Opdivo, an Immunotherapy medicine to treat cancer. She was responsible for growing revenue in the region by 28% in 2018, and successfully enabling the launch of Opdivo in China. Prior to this role Dr. Loesberg established another organization responsible for global publications, medical information, content creation, clinical trial operations, and scientific exchange. In this role she had many successes including the enablement of 18+ NEJM publications, a successful acquisition of Amylin and the subsequent divestiture of the diabetes portfolio to AstraZeneca.
At Pfizer Inc.:
Dr. Loesberg held increasing levels of responsibility and established two large US field-based organizations to support the clinical development of all assets and the evidence-based health economic data provided to customers for market access and policy decisions. She was instrumental in launching several drugs to market, including Norvasc and Lipitor.
Board Service:
In addition to her fulltime roles, Janet served as a Trustee for the BMS Patient Assistance Foundation for
10 years. She also served as a board member of the Fresh Air Society, Tamarack Camps in Michigan and as a board member of her local house of worship. Janet currently is an Alumni Recruitment Ambassador for the University of Michigan and serves on the Executive Leadership Board for All in Together (aitogether.org).
Awards and Recognitions:
She was recognized by the Healthcare Businesswomen’s Association with the Rising Star and Luminary Awards. Dr. Loesberg is well recognized for founding and leading company organizations for empowering women to have equal career opportunities.
Personal:
Janet holds a Pharm. D degree from the University of Michigan. She enjoys reading, traveling, and spending time with her husband and daughters.
Speaking At
